Acasti to participate in upcoming san francisco investor conferences in january 2024

Princeton, n.j., dec. 13, 2023 (globe newswire) -- acasti pharma inc. (nasdaq: acst) (acasti or the company), a late-stage, biopharma company advancing gtx-104, its novel intravenous formulation of nimodipine being developed to address the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (asah), today announced that chief executive officer prashant kohli will participate in the following investor and industry networking events in san francisco, california during the week of january 7-12, 2024.
ACST Ratings Summary
ACST Quant Ranking